Back to results

CompletedPhase 2

A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients

NCT00515437

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Dr Virgilio Evidente

Scottsdale, Arizona, United States

+17 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2007-07
Enrollment: 54 participants
Sponsor: Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC
Purpose: treatment

Locations (18)

Dr Virgilio EvidenteScottsdale, Arizona, United States
Dr. Ronald ZimanNorthridge, California, United States
Dr. James SuttonOxnard, California, United States
Dr. Olga KlepitskayaDenver, Colorado, United States
Dr. Fernando PaganWashington D.C., District of Columbia, United States
Dr Hubert FernandezGainesville, Florida, United States
Dr. Alan FreemanAtlanta, Georgia, United States
Dr. Katie KompolitiChicago, Illinois, United States
Dr. Robert RodnitzkyIowa City, Iowa, United States
Dr. Stephen ReichBaltimore, Maryland, United States
Dr. Brad RacetteSt Louis, Missouri, United States
Dr. Eric MolhoAlbany, New York, United States
Dr. Joseph FriedmanWarwick, Rhode Island, United States
Dr. Vanessa HinsonCharleston, South Carolina, United States
Dr. Sam KabbaniKnoxville, Tennessee, United States
Dr. Madhavi ThomasDallas, Texas, United States
Dr. Gordon SmithSalt Lake City, Utah, United States
Dr. Patrick HoganTacoma, Washington, United States

A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients — TrialFind